'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Dr. Mary Morris was a neuroscientist before she was a fertility doctor. She studied the brain in graduate school for her PhD, went to medical school, and found her way to reproductive endocrinology partly because it let her keep thinking about the hypothalamus and pituitary — the hormonal command center that drives the ovarian cycle. It’s a background unusual enough in this group to matter: MD, PhD, double board-certified, with research that has included single-cell sequencing of the mouse ovary.
Her last hospital role made the specialization explicit. Before joining Boston IVF she served as Medical Director for Oncofertility and Third Party Reproduction at Massachusetts General Hospital — one job covering two of the field’s most delicate program areas: preserving fertility for cancer patients and managing donor gamete and gestational carrier pathways. She held a Harvard Medical School faculty appointment as Assistant Professor of Obstetrics, Gynecology and Reproductive Biology alongside that directorship.
She completed her OB/GYN residency in the Massachusetts General Hospital / Brigham and Women’s Hospital combined program and her REI fellowship at Mass General. Her clinical and research interests remain fertility preservation in cancer, hereditary cancer syndromes, and infertility tied to PCOS — with 18 published papers behind her. She sees patients at Boston IVF’s Stoneham and Waltham centers, with telehealth across Massachusetts, and describes her own guiding principle plainly: “I’ve found through the years that listening is key.”
Clinical Expertise
- Oncofertility: Led the program at MGH; coordinates egg, embryo and tissue banking inside oncology treatment windows
- Hereditary Cancer Syndromes: Reproductive planning for BRCA and related mutation carriers, where preservation and genetic testing intersect
- Third-Party Reproduction: Donor egg, donor sperm and gestational carrier programs, directed at MGH level
- PCOS Infertility: A named research and clinical interest
- Reproductive Endocrine Science: From AMH research to ovarian single-cell biology — an unusual bench résumé for a private-practice REI physician
Why Choose Dr. Mary Morris
She ran the exact program your diagnosis needs. Oncofertility directorships are rare; hers was at Mass General, and it included third-party reproduction in the same portfolio.
An MD-PhD who reads primary literature as fluent text. A neuroscience doctorate means the mechanisms behind stimulation protocols are second nature to her.
Harvard faculty experience, clinic-hours availability. Former assistant professor who now practices full-time at Stoneham and Waltham.
A personal motive made public. Her sister’s four miscarriages and stillbirth, ending in a healthy baby boy, is the story she gives for choosing this field — the listening habit has roots.
Professional Affiliations
Double board-certified in Obstetrics & Gynecology and Reproductive Endocrinology & Infertility. Former Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School. Member of the American Society for Reproductive Medicine. Eighteen research publications spanning oncofertility, ovarian biology (single-cell sequencing, AMH), and reproductive endocrinology.
Suitable For
- Patients about to start chemo or radiation: Preservation triage from a former program director
- Young BRCA carriers mapping mutation status against family-building timelines
- PCOS patients whose cycles resist standard stimulation
- Donor egg or gestational carrier families wanting physician-level program experience